Since the initial description of the entity known as “in situ neuroblastoma,” thoughts about the origin, fate, and clinical significance of this anatomic finding have influenced the field of neuroectodermal tumor biology. This paper discusses the importance of the original description of in situ neuroblastoma and how the entity fits into contemporary models of neuroblastoma heterogeneity.
BeckwithJB, PerrinEV. In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol1963;43:1089–1104.
2.
GuinGH, GilbertEF, JonesB.Incidental neuroblastoma in infants. Am J Clin Pathol1969;51:126–136.
3.
TurkelSB, ItabashiHH. The natural history of neuroblastic cells in the fetal adrenal gland. Am J Pathol1974;76:225–244.
4.
BolandeRP. Developmental pathology. Am J Pathol1979;94:627–683.
5.
IkedaY, ListerJ, BoutonJM, BuyukpamukcuM.Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal. J Pediat Surg1981;16:636–644.
6.
HasegawaR, TatematsuM, ImaidaK, Neuroblastoma in situ. Acta Pathol Japon1982;32:537–546.
7.
BrodeurGM, LookAT, ShimadaH, Biological aspects of neuroblastomas identified by mass screening in Quebec. Med Pediatr Oncol2001;36:157–159.
8.
WoodsWG, GaoRN, ShusterJJ, Screening of infants and mortality due to neuroblastoma. N Engl J Med2002;346:1041–1046.
9.
ShimadaH, AmbrosIM, DehnerLP, Establishment of the International Neuroblastoma Pathology Classification (the Shimada system). Cancer1999;86:364–372.
10.
BrodeurGM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer2003;3:203–216.
